Sign in →

Epic Code LAB848 MVista Histoplasma Ag Quantitative, Spinal Fluid

Important Note

Order as Reference Miscellaneous #LAB848; indicate complete test name when ordering.

Additional Codes

Mayo Code: FHSAG

Performing Laboratory

MiraVista Diagnostics

Specimen Type

CSF
Laboratory Test Directory Note:

Lab Central Staff: All CSF specimens to Hematology first.


Specimen Required


Specimen Type: Spinal Fluid

Sources: CSF

Container/Tube: Sterile container

Specimen Volume: 0.8 mL

Collection Instructions:  Collect 0.8 mL of spinal fluid (CSF). Ship refrigerated, 0.8 mL of spinal fluid. Send specimen in a plastic, screw-capped vial refrigerated.


Specimen Minimum Volume

0.8 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
CSF Refrigerated (preferred) 14 days
  Ambient  14 days
  Frozen 

Reject Due To

Other Specimen that is too viscous to pipette. Tissue, biopsy, sputum, bronchial brush, tracheal aspirate, FNA, bone marrow aspirate, stool or samples in transport media, fixative or Isolator tubes

Day(s) Performed

Monday through Friday

 

 

Reference Values

Reference interval:        None Detected

 

Reportable Range: Positive Results reported in ng/mL from 0.20 ng/mL to 20.00 ng/mL.

 

Positive Results above 20.00 ng/mL are reported as “Above the Limit of Quantification”.

Cautions

Cross-reactions are seen with blastomycosis, paracoccidioidomycosis, penicilliosis, less frequently in coccidioidomycosis, rarely in aspergillosis and possibly sporotrichosis.

Sputolysin, sodium hydroxide and potassium hydroxide treatment degrade the analyte detected in the assay.

 

 

Reporting Name

MVista Histoplasma Ag, CSF

Method Name

Quantitative Sandwich Enzyme Immunoassay (EIA)

 

CPT Code Information

87385

LOINC Code Information

Test ID Test Order Name Order LOINC Value
FHSAG MVista Histoplasma Ag, CSF 51754-0

 

Result ID Test Result Name Result LOINC Value
Z1722 Result: 51754-0
Z1034 Interpretation Not Provided

Report Available

3 to 5 days

Test Classification

This test was developed and its performance characteristics determined by MiraVista Diagnostics. It has not been cleared or approved by the FDA; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.